Our specification refers to novel conjugated compounds that function as immunostimulants and are useful for the treatment of viral, bacterial, fungal and protozoal infections, tumours or cancers and other immunological diseases. Additionally, the conjugated compounds of the invention can be used as vaccine adjuvants.

Details about the Technology offer (click)

For more information contact Knowledge Transfer Office of the University of Ljubljana.